HPP advised Robert Bosch Venture Capital, the venture capital arm of the German Bosch Group financing innovative growth companies, on all aspects of its acquisition of shares in and 3MEUR investment into Optomed, a Finnish company providing fundus screening and diagnostics products and solutions that can help eye care professionals in prevention of blindness.
HPP’s team in the transaction included Björn Nykvist (lead partner), Partner Andrew Cotton, Senior Associate Salla Viitikko, Associate Elina Valkonen and Associate Aleksei Hanninen.
